Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 4/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14937333 | 1.00 | LMNA (0.55) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Pyridine SCHEMBL10396124 | 0.82 | LMNA (0.37) | LMNAL3MBTL1TDP1MAPTPDE4A | |
| SCHEMBL15013162 | 0.79 | LMNA (0.48) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| SCHEMBL23201 | 0.79 | LMNA (0.48) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| SCHEMBL5536370 | 0.79 | LMNA (0.48) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Mannitol SCHEMBL23066399 | 0.74 | LMNA (1.00) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Mannitol SCHEMBL13187369 | 0.74 | LMNA (1.00) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Sorbitol SCHEMBL763 | 0.74 | LMNA (1.00) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Mannitol SCHEMBL21837180 | 0.74 | LMNA (1.00) | LMNAL3MBTL1TDP1MAPTKDM4E | |
| Mannitol SCHEMBL20594082 | 0.74 | LMNA (1.00) | LMNAL3MBTL1TDP1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12535443-B2 | Photo-activated sensor for analyzing chemical and biological fluids | Taghipour, Fariborz (CA) | 2026-01-27 | — | — | US | claimed |
| CN-119280438-A | Degradable coupling patch for B ultrasonic capable of avoiding cross infection and preparation method thereof | 广州晶棋生物科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118974133-A | Two part room temperature curable heat and flame resistant composition | 汉高股份有限及两合公司 | 2024-11-15 | — | — | CN | claimed |
| US-20240295524-A1 | SELF-CALIBRATED ELECTROCHEMICAL SENSORS | VIRGINIA COMMONWEALTH UNIVERSITY | 2024-09-05 | — | — | US | claimed |
| EP-4396569-A1 | SELF-CALIBRATED ELECTROCHEMICAL SENSORS | Virginia Commonwealth University (US) | 2024-07-10 | — | — | EP | claimed |
| CN-114344263-B | Nano protein micelle for targeting macrophages to enhance tumor treatment effect and preparation method and application thereof | 杭州普略生物科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| WO-2023034192-A1 | SELF-CALIBRATED ELECTROCHEMICAL SENSORS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2023-03-09 | — | — | WO | claimed |
| CN-115737788-A | Preparation and application of metal organic framework nano probe material for efficiently depriving glucose | 福建师范大学 | 2023-03-07 | — | — | CN | claimed |
| WO-2022269249-A1 | ADDITIVE COMPOSITION | SYMPHONY ENVIRONMENTAL LTD. (GB) | 2022-12-29 | — | — | WO | claimed |
| US-20220299459-A1 | PHOTO-ACTIVATED SENSOR FOR ANALYZING CHEMICAL AND BIOLOGICAL FLUIDS | TAGHIPOUR FARIBORZ (CA) | 2022-09-22 | — | — | US | claimed |
| EP-1394129-B1 | Radiation-curable flame retardant optical fiber coatings | ADDISON CLEAR WAVE LLC (US) | 2005-01-12 | — | — | EP | claimed |
| US-20040053425-A1 | Quantitative measurement of proteins using genetically-engineeredglucose oxidase fusion molecules | BAYLOR COLLEGE OF MEDICINE | 2004-03-18 | — | — | US | claimed |
| US-6489133-B2 | REFLECTANCE READING; POROUS MATRIX IMPREGNATED WITH REAGENT;MEASURING GLUCOSE IN BLOOD | LIFESCAN, INC. | 2002-12-03 | — | — | US | claimed |
| US-6464635-B1 | Diaper with indicators sensitive to the status of the impregnated urine and visible form outside | JIMENEZ CERRATO PAULA (ES) | 2002-10-15 | — | — | US | claimed |
| EP-0739395-B1 | HEAT CURABLE TOUGHENED EPOXY RESIN COMPOSITIONS | H B FULLER AUTOMOTIVE PRODUCTS (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0739395-A1 | HEAT CURABLE TOUGHENED EPOXY RESIN COMPOSITIONS | H.B. Fuller Automotive Products, Inc. (US) | 1996-10-30 | — | — | EP | claimed |
| WO-1995012646-A1 | HEAT CURABLE TOUGHENED EPOXY RESIN COMPOSITIONS | H.B. FULLER AUTOMOTIVE PRODUCTS, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| US-5395754-A | Membrane-based immunoassay method | HYBRITECH INCORPORATED (US) | 1995-03-07 | — | — | US | claimed |
| CN-1048925-A | Producing with detection agent (the affinity thing of cholesterol) and visual developer serves as that the basis is used for method and this application of compound at the affinity enzyme compound of the visual demonstration cholesterol of patient skin surface | NII FIZ KHIM MEDITSINY (SU) | 1991-01-30 | — | — | CN | claimed |
| US-4963368-A | MICROENCAPSULATED WITH ENZYME AND SUBSTRATE IN WALLS | NABISCO BRANDS, INC. (US) | 1990-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12535443-B2 | Photo-activated sensor for analyzing chemical and biological fluids | CASR, EPCAM, L1CAM | LMNA 2345/4885L3MBTL1 2710/4885TDP1 2812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.